B. Riley Forecasts Geron’s FY2025 Earnings (NASDAQ:GERN)
Geron Co. (NASDAQ:GERN – Free Report) – Equities research analysts at B. Riley decreased their FY2025 EPS estimates for Geron in a research report issued on Wednesday, February 26th. B. Riley analyst K. Patel now expects that the biopharmaceutical company will earn ($0.11) per share for the year, down from their prior estimate of ($0.08). […]
Geron Co. (NASDAQ:GERN – Free Report) – Equities research analysts at B. Riley decreased their FY2025 EPS estimates for Geron in a research report issued on Wednesday, February 26th. B. Riley analyst K. Patel now expects that the biopharmaceutical company will earn ($0.11) per share for the year, down from their prior estimate of ($0.08). […]
